THTyler Hack

Tyler Hack

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tyler Hack has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A 27-nW Wake-Up Receiver With a Quartz Transformer Matching Network Achieving −71.9-dBm Sensitivity and −46-dB SIR at 0.8% Offset

    by Joshua Rosenberg, Mary E. Galanko Klemash, Ryan Rudy, Tyler Hack, Alexander B. Kozyrev, Prasad Gudem, Andy Walker, Drew A. Hall, Sarah S. Bedair

    This work reports the first ultra-low power wake-up receiver (WuRX) to be integrated with a quartz micro-electromechanical systems (MEMS) transformer-based matching network (MN), achieving the best signal-to-interference ratio (SIR) compared to state-of-the-art sub-100 nW receivers. A quartz resonant piezoelectric transformer (PT) was chosen for its high loaded Q (~19,000), enabling large, passive voltage gain – a necessity for low-power radios where active RF amplification consumes too much power. Optimization of the CMOS envelope detector (ED) input impedance and number of ED stages preserves the high Q of the preceding MEMS transformer while maintaining a high passive gain of 27 dB and a narrow bandwidth of 2 kHz at 50 MHz. The quartz PT is designed for maximum voltage gain from a $50~\Omega $ source to the ED input. The 6-stage ED is designed with an input impedance greater than 1M $\Omega $ and a conversion gain of 264.9 V-1 to maximize sensitivity without de-Qing the transformer. The WuRX is implemented in a 65-nm CMOS process and achieves a sensitivity of −71.9 dBm while consuming just 27 nW. The measured SIR is −46 dB at a 0.8% frequency offset due to the narrowband filtering from the transformer.


  • From Wearables to Implantables: Harnessing Sensor Technologies for Continuous Health Monitoring

    by Asish Koruprolu, Tyler Hack, Omid Ghadami, Aditi Jain, Drew A. Hall

    Continuous health monitoring by placing sensors onto and into the human body has emerged as a pivotal approach in healthcare. This paper delves into the vast array of opportunities presented by instrumenting the body using wearable, ingestible, injectable, and implantable sensors. These sensors enable the continuous monitoring of vital signs, biomarkers, and other crucial health metrics, thus assessing an individual’s physiological state. This comprehensive health data empowers healthcare providers and individuals alike to make informed decisions and take timely action. Moreover, integrating sensors into the human body enables personalized medicine, enhances disease detection and management, and offers possibilities for proactive health interventions and preventive care to improve overall well-being.


  • Mitigating Medication Tampering and Diversion via Real-Time Intravenous Opioid Quantification

    by Tyler Hack, Joel Bisarra, Saeromi Chung, Shekher Kummari, Drew A. Hall

    Opioid tampering and diversion pose a serious problem for hospital patients with potentially life-threatening consequences. The ongoing opioid crisis has resulted in medications used for pain management and anesthesia, such as fentanyl and morphine, being stolen, substituted with a different substance, and abused. This work aims to mitigate tampering and diversion through analytical verification of the administered drug before it enters the patient. We present an electrochemical-based sensor and miniaturized wireless potentiostat that enable real-time intravenous (IV) monitoring of opioids, specifically fentanyl and morphine. The proposed system is connected to an IV drip system during surgery or post-operation recovery. Measurement results of two opioids are presented, including calibration curves and data on the sensor performance concerning pH, temperature, interference, reproducibility, and long-term stability. Finally, we demonstrate real-time fluidic measurements connected to a flow cell to simulate IV administration and a blind study classified using a machine-learning algorithm. The system achieves limits of detection (LODs) of 1.26 μg/mL and 2.75 μg/mL for fentanyl and morphine, respectively, while operating with >1-month battery lifetime due to an optimized ultra-low power 36 μA sleep mode.